Why it was recalled
Subpotent Drug
Product description
Levothyroxine Sodium Tablets, USP, 88 mcg (0.088 mg), 100 Tablets (10 x 10 unit dose blisters) per carton, Rx only, Packaged and Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, IN 46268 USA. NDC: 0904-6952-61
Lot numbers, UPCs & expiration codes
Lot #: N02310, Exp. Date 01/2027
Where it was sold
Nationwide in the USA.
What to do if you have this product
- Compare the lot number and expiration date on your package with the codes above.
- Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
- If you have symptoms you think are related, contact your doctor. In an emergency call 911.
- Report side effects to FDA MedWatch at 1-800-FDA-1088.
Recall details
- Recall number
- D-0703-2026
- Classification
- Class II
- Status
- Ongoing
- Recall initiated
- Jul 13, 2026
- FDA report date
- Jul 29, 2026
- Quantity
- N/A
- Recall type
- Voluntary: Firm initiated
- Recalling firm
- Major Pharmaceuticals
Original FDA data
Every field from FDA enforcement report D-0703-2026, exactly as published.
Show all FDA fields
- City
- Dublin
- State
- OH
- Status
- Ongoing
- Country
- United States
- Event ID
- 99399
- Address
- 7000 Cardinal Pl
- Code information
- Lot #: N02310, Exp. Date 01/2027
- Postal code
- 43017-1091
- Report date
- Jul 29, 2026
- Product type
- Drugs
- Recall number
- D-0703-2026
- Classification
- Class II
- Recalling firm
- Major Pharmaceuticals
- Reason for recall
- Subpotent Drug
- Voluntary / mandated
- Voluntary: Firm initiated
- Product description
- Levothyroxine Sodium Tablets, USP, 88 mcg (0.088 mg), 100 Tablets (10 x 10 unit dose blisters) per carton, Rx only, Packaged and Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, IN 46268 USA. NDC: 0904-6952-61
- Distribution pattern
- Nationwide in the USA.
- Recall initiation date
- Jul 13, 2026
- Initial firm notification
- Letter
- Center classification date
- Jul 17, 2026